Novorapid Chu Flexpen



Indications and Reactions:

Role Indications Reactions
Primary
Type 1 Diabetes Mellitus 27.2%
Type 2 Diabetes Mellitus 21.3%
Insulin-requiring Type Ii Diabetes Mellitus 9.5%
Diabetes Mellitus 8.5%
Hypertension 6.6%
Diabetes Mellitus Insulin-dependent 4.4%
Drug Use For Unknown Indication 4.2%
Asthma 2.4%
Gastric Ulcer 1.8%
Pustular Psoriasis 1.8%
Hyperuricaemia 1.6%
Atrial Fibrillation 1.2%
Dermatomyositis 1.2%
Diabetic Retinopathy 1.2%
Gastritis 1.2%
Insulin-requiring Type 2 Diabetes Mellitus 1.2%
Product Used For Unknown Indication 1.2%
Renal Failure Chronic 1.2%
Rheumatoid Arthritis 1.2%
Angina Pectoris 1.0%
Suicide Attempt 17.7%
Hypoglycaemia 15.3%
Hepatic Function Abnormal 9.7%
Hypoglycaemic Coma 4.8%
Intentional Overdose 4.8%
Oedema Peripheral 4.8%
Blood Glucose Fluctuation 4.0%
Hypoglycaemic Encephalopathy 4.0%
Liver Disorder 4.0%
Anti-insulin Antibody Positive 3.2%
Interstitial Lung Disease 3.2%
Threatened Labour 3.2%
Weight Increased 3.2%
Wrong Drug Administered 3.2%
Feeling Abnormal 2.4%
Hyperglycaemia 2.4%
Hypoglycaemic Unconsciousness 2.4%
Pregnancy 2.4%
Rash 2.4%
Retinal Haemorrhage 2.4%
Secondary
Type 2 Diabetes Mellitus 38.3%
Diabetes Mellitus 9.9%
Type 1 Diabetes Mellitus 8.4%
Insulin-requiring Type Ii Diabetes Mellitus 8.0%
Product Used For Unknown Indication 6.9%
Drug Use For Unknown Indication 5.9%
Hypertension 5.9%
Diabetes Mellitus Insulin-dependent 3.2%
Insulin-requiring Type 2 Diabetes Mellitus 3.2%
Dyslipidaemia 1.5%
Hyperlipidaemia 1.1%
Rheumatoid Arthritis 1.1%
Benign Prostatic Hyperplasia 0.9%
Cerebral Infarction 0.9%
Herpes Zoster 0.9%
Diabetic Neuropathy 0.8%
Myocardial Infarction 0.8%
Tension Headache 0.8%
Constipation 0.7%
Diabetic Ketoacidosis 0.6%
Hypoglycaemia 25.9%
Diabetes Mellitus Inadequate Control 8.9%
Suicide Attempt 7.0%
Anti-insulin Antibody Positive 5.7%
Hyperglycaemia 5.7%
Blood Glucose Fluctuation 5.1%
Weight Increased 5.1%
Drug Hypersensitivity 4.4%
Hypoglycaemic Coma 4.4%
Rash 4.4%
Vomiting 3.8%
Diabetic Ketoacidosis 2.5%
Hypoglycaemic Encephalopathy 2.5%
Hypoglycaemic Unconsciousness 2.5%
Liver Disorder 2.5%
Hepatic Function Abnormal 1.9%
Injection Site Swelling 1.9%
Insulin Autoimmune Syndrome 1.9%
Interstitial Lung Disease 1.9%
Oedema Peripheral 1.9%
Concomitant
Type 2 Diabetes Mellitus 22.3%
Type 1 Diabetes Mellitus 14.4%
Spinal Osteoarthritis 11.5%
Insomnia 7.2%
Gastric Ulcer 5.8%
Insulin-requiring Type 2 Diabetes Mellitus 5.8%
Hypertension 5.0%
Constipation 3.6%
Headache 3.6%
Nausea 3.6%
Pyrexia 3.6%
Diabetes Mellitus 2.9%
Diabetes Mellitus Insulin-dependent 2.2%
Diabetic Nephropathy 2.2%
Latent Autoimmune Diabetes In Adults 2.2%
Psoriasis 1.4%
Autonomic Neuropathy 0.7%
Drug Use For Unknown Indication 0.7%
Dyslipidaemia 0.7%
Hypothyroidism 0.7%
Sensory Disturbance 13.3%
Hepatic Function Abnormal 6.7%
Hepatitis A 6.7%
Hypoglycaemia 6.7%
Intestinal Obstruction 6.7%
Muscle Spasms 6.7%
Rash 6.7%
Type Iv Hypersensitivity Reaction 6.7%
Urticaria 6.7%
Anti-insulin Antibody Positive 3.3%
Hypoglycaemic Unconsciousness 3.3%
Ileus Paralytic 3.3%
Latent Autoimmune Diabetes In Adults 3.3%
Liver Disorder 3.3%
Oxygen Saturation Decreased 3.3%
Pancreatitis Acute 3.3%
Pruritus 3.3%
Renal Disorder 3.3%
Sudden Death 3.3%